There Are Reasons For Optimism As We Launch The New Year

Our hopes should by buoyed, for instance, by the knowledge that the National Institutes of Health is now led by Harold Varmus, a distinguished biologist. Varmus appears eager to defend the clear merits of basic biomedical investigation and to voice the demand, on behalf of the nation's bench scientists, for the financial--and philosophical--support that curiosity-driven research clearly deserves. Not unrelated is the sense of confi

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Our hopes should by buoyed, for instance, by the knowledge that the National Institutes of Health is now led by Harold Varmus, a distinguished biologist. Varmus appears eager to defend the clear merits of basic biomedical investigation and to voice the demand, on behalf of the nation's bench scientists, for the financial--and philosophical--support that curiosity-driven research clearly deserves.

Not unrelated is the sense of confidence we can gain from the recent appointment of Neal Lane as director of the National Science Foundation. On page 11 of this issue, we present an exclusive interview with Lane, who also appears to understand the value of untargeted research. Lane, of course, will have his hands full in his efforts to accommodate the interests of pure research while under pressure from powerful figures in government and industry who insist that federally supported science must have a practical, fiscal, near-term--if not immediate--payoff.

Also most gratifying ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies